incorrect diluents, volumes, or technique can cause potency loss, contamination, particulate formation, and inaccurate dosing with serious clinical consequences
Electrophysiological recordings further supported this, revealing that Dihexa caused a 1.6-fold increase and Nle-AngIV caused a 1.7-fold increase in the frequency of AMPA-mediated mEPSCs compared to vehicle-treated neurons, indicating an expansion of functional synapses without altering individual synapse properties such as amplitude, rise, or decay times
A dermatology review flagged that there are essentially no adequate studies of intravenous glutathione for skin lightening, and that its safety for repeated IV use has not been established (a dermatology review concluding that IV glutathione for skin lightening has inadequate safety data)
10.1038/s41366-018-0015-3
What We Know So Far The two-day meeting was convened by the FDA's Pharmacy Compounding Advisory Committee, which was recently overhauled with many new members who have ties to the peptide industry, according to NPR
